Best of ASCO - 2014 Annual Meeting

 

Welcome

Care Delivery/Models of Care

Health Services Research, Clinical Informatics, and Quality of Care

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
24-hour cancer clinic: An approach to same-day care.

Jonathan Thomas Kapke

6544

A comprehensive initiative to optimize accrual to neuro oncology clinical trials.

Mathew England Grubman

e18546

A multidisciplinary toxicity team for cancer immunotherapy-related adverse events.

Jarushka Naidoo

6538

A quality improvement project to address oncofertility in children and adolescents with cancer: Development of an oncofertility roadmap.

Lindsay Hoogenboom

e18536

A retrospective review of complication rates of Ommaya reservoir placement for intrathecal medication administration.

Raphael Bosse

e18532

Access to smoking cessation resources for cancer patients across Canada and systemic barriers to implementing change in systems process.

Michelle Halligan

e18539

Accessing tissue for research: Pathology provider policies and attitudes to tumor sample use.

Elizabeth Chien Hern Liow

e18561

Achieving pain control with patient-reported personalized pain goals among patients with cancer in the inpatient setting.

Maria Alma Rodriguez

e18534

Acute myeloid leukemia: Does one size fit all? A retrospective analysis of outcomes of therapy at Moi Teaching and Referral Hospital in Eldoret, Kenya.

Christopher Mwaniki Wanjiku

e18529

Association of the adoption of immune checkpoint inhibitor therapy (ICT) with prevalence of tumor mutation burden (TMB) in sixteen cancer types.

Leigh Baumgart

e18557

Burdensome end-of-life (EOL) transitions among frail older adults with advanced cancer.

Daniel E Lage

6534

Can we discharge mastectomy patients directly home?

Elizabeth Peace Tito

e18547

Cancer genomics at the edge of public health and precision medicine in Belgium: A national perspective.

Marc Van den Bulcke

e18543

Cancer pain in the emergency department: A multicenter study of the Comprehensive Oncologic Emergencies Research Network.

Christopher John Coyne

6541

Cancer survival in the context of growing hospital participation in Medicare ACOs.

Stephen Matthew Schleicher

6543

Clinical trial accrual and patient survival in oncology.

Nicholas George Zaorsky

e18513

Comparison of routine multidisciplinary lung cancer care (MDC) compared to enhanced MDC care (EMDC) at Geisinger Health: A prospective, cohort study.

Christian S. Adonizio

e18528

Current utilization paradigm of PD-1/PD-L1 inhibitors in unapproved area: A multi-institutional cohort study in China.

Shaodong Hong

e18503

Defining survivorship and surveillance with evidence.

Robert Dood

6528

Depression and anxiety in oncology nurses.

Özge Keskin

e18552

Design and implementation of a risk identification tool to improve oncology patient management.

Garrett Young

e18521

Developing a telemedicine triage system to manage patient flow at a high volume cancer center urgent care.

Christian Otto

e18517

Differential effects of increasing time to treatment initiation (TTI) for solid tumors.

Thomas James Galloway

e18520

Diffusion of innovation in oncology: A case study of immuno-oncology (IO) adoption for advanced non-small lung cancer (aNSCLC) patients across practices in the US.

Caroline Savage Bennette

6537

Do accountable care organizations impact prevalence of mammography and colonoscopies among Medicare beneficiaries?

Maxine Sun

e18516

Do accountable care organizations impact prostate cancer screening?

Quoc-Dien Trinh

6546

Early discharge after induction chemotherapy for acute myeloid leukemia: Safety outcomes and hospital readmissions.

Nikita V. Baclig

6532

East Carolina University clinical experience study: Utilization of liquid biopsy to determine time to diagnosis and treatment in non-small cell lung cancer (NSCLC).

Sweta Jonnalagadda

e18519

ECHO palliative care in Africa (ECHO-PACA): Improving access to quality palliative care.

Sriram Yennu

6545

Effects of molecular tumor board and different NGS panels implementation for the treatment of patients with cancer.

Christian Diego Rolfo

e18511

Embedding palliative care in an outpatient oncology specialty clinic.

Judith Salmon Kaur

e18560

Emergency department (ED) presenting symptom clusters for chemotherapy patients.

Robert Michael Daly

e18509

Estrogen receptor (ER) and progesterone receptor (PR) retest rate in breast ductal carcinoma in situ (DCIS) surgical excision specimens.

Lilit Karapetyan

e18524

Evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction.

Carly Barron

e18548

Exploiting machine learning in local treatment strategies in cancer patients with bone metastases.

Wang Zhiyu

e18505

Facility volume and head and neck squamous cell carcinoma: Trends and effect on survival.

Roy Xiao

e18518

Factors associated with follow-up physician visits among women with early stage breast cancer.

Farah Quyyumi

6531

Feasibility of cancer treatment without blood transfusion in Jehovah’s Witnesses.

Rachael Chang

e18554

Financial toxicity in patients with colorectal cancer and neuroendocrine tumors.

Leonidas Apostolidis

6533

Impact of a natural language processing (NLP) tool on patient identification, navigator efficiency, and time to first treatment.

Brook Blackmore

e18512

Impact of National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP) and NCI Community Oncology Research Program (NCORP) on clinical trial (CT) activities in a community cancer center.

Mehmet Sitki Copur

e18500

Impact on treatment adherence, side effects control, patients QoL, and rehospitalization rate through new management of oral chemotherapy.

Ida Pavese

e18533

Implementation of breast cancer pathway for genetic counseling and testing in multi-state health system.

Stephanie L. Graff

6521

Implementation of individualized care plans in high risk oncology patients: A team based model to decrease unnecessary utilization.

Girish Chandra Kunapareddy

6547

Implementation of precision medicine clinical care pathways and a systemwide molecular tumor board at Henry Ford Health System (HFHS).

Nadia Z Haque

e18541

Improving care delivery for patients with rare cancers: A phase II trial of durvalumab in combination with tremilumimab in subjects with advanced rare tumors in a large community health care system.

William Jeffery Edenfield

e18535

Integrating tobacco treatment into cancer care: A first snapshot of RCT findings.

Elyse R. Park

6505

Key facilitators to implementing smoking cessation support for cancer patients across Canada.

Deb Keen

e18555

Knowledge, attitudes, and intentions toward fertility preservation awareness among oncologists in China.

Qing Li

e18537

Lung cancer screening rates: Data from the lung cancer screening registry.

Danh Pham

6504

Mainstreaming BRCA mutation testing for ovarian cancer patients: Addressing health inequalities.

Danielle Lisa Shaw

e18526

Meeting the needs of women at high risk for breast cancer: Facilitated group visits.

Kathryn Trotter

e18508

Methodologic challenges of defining oncology provider networks from administrative claims data.

Karyn Beth Stitzenberg

6523

National Comprehensive Cancer Network (NCCN) infusion efficiency workgroup study: Optimizing patient flow in infusion centers.

Jessica Sugalski

e18502

Neutropenic fever outcomes per institutions’ teaching status.

Zachary Michael Trisel

e18553

Nurse practitioner and physician assistant oncology workforce for older adults.

Lorinda Adaire Coombs

e18514

Nutritional status in cancer: Perspectives of healthcare professionals.

Niamh O'Donoghue

e18550

Outcomes of embedded palliative care outpatients consults on timing of palliative care access, symptoms, and end-of-life quality indicators among advanced non-small cell lung cancer patients.

Sriram Yennu

6536

Patient comorbid conditions and cancer clinical trial participation.

Joseph M. Unger

6540

Patient knowledge, attitudes, and expectations of cancer immunotherapies.

Simranjot Shokar

e18551

Patient predictive factors for clinical trial participation.

Adrianne Rose Mallen

6530

Patient-reported satisfaction with multidisciplinary (MD) v serial care (SC) for lung cancer.

Kenneth Daniel Ward

6535

Physicians’ comfort levels with prescriptions for cancer comorbidities that they and other healthcare providers write.

Chiahung Chou

e18523

Practice transformation: Early impact of OCM on hospital admissions.

Molly Mendenhall

6542

Practice variance as determinant of cost in the oncology care model (OCM).

Ariel Sandhu

e18563

Radar-guided vs. wire localization for non-palpable breast lesions.

Timothy Borjas

e18525

Reportable actionability versus pragmatic actionability: Implementing precision medicine at three large health systems.

Michael A. Thompson

6539

Results from a pilot of an innovative 4R Cancer Care Delivery Model: Impact on patient self-management.

Julia Rachel Trosman

6527

Results of a pan-Canadian approach to systems change for smoking cessation support in Canadian cancer centers.

Michelle Halligan

e18538

Risk stratification and predictive value of the HOSPITAL score for oncology patient readmissions.

Anu Radha Neerukonda

6548

Safety and feasibility of enhanced recovery after surgery program in older patients undergoing gynecologic oncological surgery.

Alexandre de Nonneville

e18559

The application of cognitive computing technology in genomics in precision oncological medicine: The Sistemas Genomicos Experience.

Lucía Pérez

e18544

The effect of a lay health worker-led symptom assessment intervention for patients on patient-reported outcomes, healthcare use, and total costs.

Manali I. Patel

6502

The establishment of a new medical model for tumor treatment combined with Watson for Oncology, MDT and patient involvement.

Juemin Fang

e18504

The IBM Cancer Guidelines Navigator, a tool to standardize and raise the quality of cancer care in Sub-Saharan Africa.

Daniel Strauss

e18556

The role of real-world evidence in clinical care: A survey of oncology leaders.

Melissa Stahl

e18515

Treatment patterns among patients diagnosed with stage IV cancers who died within one month of diagnosis.

Helmneh M. Sineshaw

6526

Trends and disparities in place of death for cancer patients in the United States, 1999-2015.

Fumiko Ladd Chino

6522

Trends related to program participation, implementation, best practices, challenges and resource requests among oncology care model (OCM) participants.

Daniel Gutkin

6524

Uptake and efficacy of using a state quitline to address tobacco use by cancer patients treated in community cancer centers.

Anna E Schulze

e18530

Use of next-generation sequencing tests to guide cancer treatment: Results from a survey of U.S. oncologists.

Andrew N. Freedman

6529

Value-based healthcare delivery models in oncology: A systematic review.

Emeline Aviki

6525